The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-11), NeueHealth's 9-Day RSI is 54.68.
The industry rank for NeueHealth's 9-Day RSI or its related term are showing as below:
NEUE's 9-Day RSI is not ranked
in the Healthcare Plans industry.
Industry Median: 61.745
vs NEUE: 54.68
NeueHealth (NYSE:NEUE) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
NeueHealth 9-Day RSI Related Terms
NEUE vs PFHO, UNH, CVS: 9-Day RSI Comparison
For the Healthcare Plans subindustry, NeueHealth's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeueHealth 9-Day RSI vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, NeueHealth's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where NeueHealth's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeueHealth (NEUE) has a 9-Day RSI of 54.68 as of Jul. 11, 2026.
Is NeueHealth's 9-Day RSI too high?
NeueHealth's current 9-Day RSI is 54.68. The Healthcare Plans industry median 9-Day RSI is 61.75. NeueHealth's value of 54.68 is 11.4% below this industry median. Overall, NeueHealth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does NeueHealth's 9-Day RSI compare to PFHO and UNH?
NeueHealth's 9-Day RSI of 54.68 can be compared against companies in the Healthcare Plans industry. The industry median 9-Day RSI is 61.75. NeueHealth's value of 54.68 is 11.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Plans company?
The median 9-Day RSI among Healthcare Plans companies is 61.75, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeueHealth's current 9-Day RSI of 54.68 is 11.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median 9-Day RSI is 61.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeueHealth's current 9-Day RSI is 54.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeueHealth stock overvalued right now?
NeueHealth (NEUE) has a current 9-Day RSI of 54.68. The current 9-Day RSI is 54.68 and 11.4% below the Healthcare Plans industry median of 61.75. NeueHealth's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For NeueHealth (NEUE), the current 9-Day RSI is 54.68 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
20GF Score
Get the complete analysis for NEUE
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEUE has been successfully added to your 